Magnera Corp. introduced a new PFAS‑free nonwoven textile that delivers fluid repellency for medical gowns, drapes, and other protective apparel, a launch that comes as regulatory scrutiny of PFAS intensifies worldwide.
The new material meets stringent safety and compliance standards required by healthcare providers while eliminating PFAS. It offers the same durability and barrier performance as PFAS‑based fabrics but without the environmental persistence and health concerns that have prompted bans and restrictions in several U.S. states and the European Chemicals Agency.
Magnera’s move aligns with its broader strategy to pivot toward advanced, sustainable technologies. The company has positioned the launch to capture demand from customers in healthcare, personal care, wipes, and specialty building markets that are increasingly seeking compliant, eco‑friendly solutions.
Paul Harmon, Chief Innovation and Marketing Officer, said the solution “meets the industry's stringent standards for protection, comfort, and compliance in articles such as surgical gowns or drapes, while reducing potential pollutants.” The launch underscores Magnera’s commitment to sustainability and regulatory compliance.
The PFAS‑free textile is expected to strengthen Magnera’s competitive position in the specialty‑materials market and open new revenue opportunities in regulated sectors, reinforcing the company’s focus on innovation and environmental stewardship.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.